Recent insider trading activity from Smith Robin L, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 30, 2025 | Matinas BioPharma Holdings, Inc. | $MTNB | Smith Robin L | Director | A | Stock Option (right to Buy) | 11600 | $0.00 | 11,600.0000 | 5,086,985 | 9999.99% | 0.23% |